Asia - Pacific Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia - Pacific Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1137 | Pages: 134 | November 2016 | Region: Asia Pacific


The Asia - Pacific Aptamers Market was worth $ 24 million in 2016 and estimated to reach $ 66 million by the end of 2021 with a growing potential of 22.50 %.  Asia – Pacific aptamers market is predicted to have the highest CAGR over the forecast Period. Growth in the market will be driven by increasing use of aptamers for diagnostics, therapeutics and drug discovery.

Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. Aptamers can be chosen from a pool of random-sequence oligonucleotides to bind a wide range of bio medically relevant proteins with specificities and affinities that are as good as antibodies. Aptamers are multipurpose and cost effective which offer alternative solutions to the antibodies. Aptamers exhibit important advantages relative to protein therapeutics in terms of synthetic accessibility, size and modification by medicinal chemistry.

The Major factors driving the growth of the Asia - Pacific market are advancement in technology, Growing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy of aptamers in binding. Ethical issues for the aptamers that are obtained from animals, Stringent regulations in use of aptamers may hinder the growth of the market.  

The Asia - Pacific Aptamers Market is broadly categorized by type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.

Based on Application the market is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres and on the basis of geography, the Asia - Pacific Aptamers market is analysed under various regions namely Japan, China, India and Australia.

Some of the key players operating in Asia - Pacific Aptamers region are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Aptamers Market By Type, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Peptide Aptamers Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Nucleic Acid Aptamers Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Aptamers Market By Application, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Therapeutics Development Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Diagnostics Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Research and Development Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Aptamers Market By End users, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Bio-Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Academic and Rsearch centers Market By Region, From 2016-2021 ( USD Billion )
  12. Japan Aptamers Market By Type, From 2016-2021 ( USD Billion )
  13. Japan Aptamers Market By Application, From 2016-2021 ( USD Billion )
  14. Japan Aptamers Market By End users, From 2016-2021 ( USD Billion )
  15. China Aptamers Market By Type, From 2016-2021 ( USD Billion )
  16. China Aptamers Market By Application, From 2016-2021 ( USD Billion )
  17. China Aptamers Market By End users, From 2016-2021 ( USD Billion )
  18. India Aptamers Market By Type, From 2016-2021 ( USD Billion )
  19. India Aptamers Market By Application, From 2016-2021 ( USD Billion )
  20. India Aptamers Market By End users, From 2016-2021 ( USD Billion )
  21. Australia Aptamers Market By Type, From 2016-2021 ( USD Billion )
  22. Australia Aptamers Market By Application, From 2016-2021 ( USD Billion )
  23. Australia Aptamers Market By End users, From 2016-2021 ( USD Billion )
  24. Asia-Pacific Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
  25. Asia-Pacific DNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  26. Asia-Pacific RNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  27. Asia-Pacific XNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  28. Japan Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
  29. China Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
  30. India Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
Middle East And Africa Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Applicat...
Latin America Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Rese...
Asia Pacific Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Resea...
Europe Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, C...
North America Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Rese...
Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) Application (Research, Cancer, Im...
Middle East And Africa Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microp...
Latin America Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Acc...
Asia Pacific Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Acce...
Europe Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessorie...
North America Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Acc...
Laboratory Filtration Market By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), By Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessories), By ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.